Accuray Incorporated announced the company is expanding its global footprint with the introduction of its CyberKnife platform in Africa, making it possible for more...
Checkpoint Surgical announced the addition of CHECKPOINT GEMINI™ to the company's industry-leading line of intraoperative nerve stimulators. An addition to the company's flagship CHECKPOINT...
Centricity Vision Inc., a global ophthalmic technology company and developer of the ZEPTO IOL Positioning System, announced the launch of ZEPTO Plus™, a new,...
The U.S. Food and Drug Administration approved Relyvrio (sodium phenylbutyrate/taurursodiol) to treat patients with amyotrophic lateral sclerosis (ALS), commonly referred to as Lou Gehrig's...
Synaptogenix, Inc., an emerging biopharmaceutical company developing regenerative therapeutics for neurodegenerative disorders, commented on the positive Phase 3 trial results for Lecanemab announced last...
